Back to overview
Keto recipes

Insulin resistance

Insulin resistance can have drastic consequences for your health and a significant impact on your daily quality of life. It doesn’t only affect people who are overweight. You can also be insulin resistant even if you have a normal body weight or if you’re underweight.

In this article, I will explain everything about insulin resistance, not only what it is but also what the consequences can be.

Table of Contents:

What is insulin resistance

Let’s start with the basics: what insulin is and what it does.

Insulin is a hormone responsible for regulating glucose metabolism. After eating a carbohydrate-rich meal, your body releases glucose (sugar), which raises your blood sugar levels and triggers the production of insulin.

Insulin helps your cells open up, allowing glucose to enter and be converted into energy. You can think of insulin as a key. Any glucose that isn’t immediately needed for energy is stored in the liver, muscles, and fat cells.

What happens when you continue to consume more glucose than needed?

When you keep supplying too much glucose to your cells, they become overwhelmed. As a result, your cells no longer allow insulin in (without insulin, glucose can’t enter the cell).

Consequently, your body produces more insulin because it needs to do something with the sugars racing through your bloodstream. The problem is that since cells won’t accept the insulin, there’s only one place left for the glucose to go—your fat cells. Glucose gets stored in your fat cells, leading to weight gain, particularly visceral fat (fat around your organs).

Your body becomes resistant to insulin

Insulin is still produced, but since cells won’t accept it, it becomes ineffective. This results in excess glucose that your body can’t use as intended. In simple terms, insulin resistance means your cells resist insulin, preventing glucose from entering the right cells.

Symptoms

  • Losing weight becomes increasingly difficult, or you gain weight quickly
  • You have low energy and wake up feeling tired
  • After eating a carbohydrate-rich meal, you quickly feel tired and lethargic
  • You frequently experience hunger and cravings for carbohydrates
  • ou never feel satisfied after eating (e.g., one cookie is not enough)

It’s essential to keep in mind that experiencing one of the above symptoms doesn’t necessarily mean you have insulin resistance, but it’s essential to monitor these signs.

Possible consequences of insulin resistance

  • Pre-diabetes
  • Type 2 diabetes (insulin resistance is always the cause)
  • High blood pressure
  • Obesity
  • Fatty liver disease
  • Cardiovascular diseases
  • Hormonal issues
  • Alzheimer’s disease (also known as diabetes type 3)
  • Certain types of cancer
  • Increased risk of chronic inflammatory diseases
  • Various autoimmune diseases

As you can see, the possible consequences of insulin resistance are severe. Each of these conditions can significantly impact your quality of life.

It’s even more dangerous for slim people

The fat (caused by an excess of glucose) is stored around your organs, which is even more concerning. The danger lies in the fact that it’s not visible from the outside.

For example, in the world of sports, it’s not uncommon to hear about top athletes experiencing “spontaneous” heart attacks without prior warnings. They consume a lot of carbohydrates, but their extensive physical activity keeps them slim, making them appear healthy. This highlights the importance of paying attention to other signals, not just body fat.

What should you do if you have it

Unfortunately, insulin resistance cannot be cured. However, you can improve symptoms and prevent them from worsening by adopting a low-carb (preferably ketogenic) diet. This way, you significantly reduce your glucose intake.
Keto recipes
By adopting a low-carb or ketogenic diet, your body switches to using fat as fuel. Because you’re consuming so few carbohydrates, your body requires much less insulin and is under much less strain. This results in more stable and lower blood sugar levels.

The difference made by eating pure and unprocessed low-carb foods is noticeable in most people within a few days. Symptoms resulting from insulin resistance generally start to decrease within a few days, and many people with type 2 diabetes can often start reducing their medication within a few weeks, ultimately achieving complete freedom from medication!

Prevention is Always Better than Cure!

As you’ve read earlier in this article, there are serious consequences to insulin resistance. Since curing it isn’t an option (only managing it), it’s wise to try to prevent insulin resistance from occurring in the first place. Especially considering that, on average, 1 in 4 people have this condition, the chances are quite high that you could develop it too.

How can you prevent insulin resistance?
The answer to this question is actually very simple and straightforward:
Stop consuming large amounts of glucose!

A ketogenic lifestyle is not just for people looking to lose weight or those who already have health issues. In fact, it offers so many benefits, not only for physical health but much more. If you want to learn more about that, read this article.

Sources

Chia-Hsuin Chang, Jou-Wei Lin, Li-Chiu Wu, Mei-Shu Lai, Lee-Ming Chuang, Oral Insulin Secretagogues, Insulin, and Cancer Risk in Type 2 Diabetes Mellitus, The Journal of Clinical Endocrinology & Metabolism, Volume 97, Issue 7, 1 July 2012, Pages E1170–E1175, https://doi.org/10.1210/jc.2012-1162

Ormazabal, V., Nair, S., Elfeky, O. et al. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol 17, 122 (2018). https://doi.org/10.1186/s12933-018-0762-4

Won, Ki-Bum MDa; Kim, Yun Seok MDb; Lee, Byoung Kwon PhDc; Heo, Ran MDd; Han, Donghee MDe; Lee, Ji Hyun MDe; Lee, Sang-Eun MDe; Sung, Ji Min PhDe; Cho, Iksung MDf; Park, Hyung-Bok MDg; Cho, In-Jeong MDe; Chang, Hyuk-Jae PhDe,*. The relationship of insulin resistance estimated by triglyceride glucose index and coronary plaque characteristics. Medicine 97(21):p e10726, May 2018. | DOI: 10.1097/MD.0000000000010726

orchen, L.C. Cardiometabolic Risk in PCOS: More than a Reproductive Disorder. Curr Diab Rep 17, 137 (2017). https://doi.org/10.1007/s11892-017-0956-2

R.Giannarelli, M.Aragona, A.Coppelli, S.Del Prato, Reducing insulin resistance with metformin: the evidence today, https://doi.org/10.1016/S1262-3636(03)72785-2

Sander Kersten, Mechanisms of nutritional and hormonal regulation of lipogenesis, https://doi.org/10.1093/embo-reports/kve071

Vasilis Tsimihodimos, Clicerio Gonzalez-Villalpando, James B. Meigs and Ele Ferrannini, Hypertension and Diabetes Mellitus, https://doi.org/10.1161/HYPERTENSIONAHA.117.10546Hypertension. 2018;71:422–428

Yu–Xiao Yang, Sean Hennessy, James D. Lewis, Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients, DOI:https://doi.org/10.1053/j.gastro.2004.07.011

Eleuterio Ferrannini, M.D., Giuseppe Buzzigoli, Riccardo Bonadonna, M.D., Maria Antonietta Giorico, Marco Oleggini, M.D., Linda Graziadei, M.D., Roberto Pedrinelli, M.D., Luigi Brandi, M.D., and Stefano Bevilacqua, M.D., Insulin Resistance in Essential Hypertension, DOI: 10.1056/NEJM198708063170605

Chia-Hsuin Chang, Jou-Wei Lin, Li-Chiu Wu, Mei-Shu Lai, Lee-Ming Chuang, K. Arnold Chan, Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus†‡, https://doi.org/10.1002/hep.25509

J.K. Olijhoek, F.M.A.C. Martens, J.D. Banga, F.L.J. Visseren, Het metabool syndroom: een cluster van vasculaire risicofactoren, Ned Tijdschr Geneeskd. 2005;149:859-65

rion, K.A., Corkey, B.E. Hyperinsulinemia: a Cause of Obesity?. Curr Obes Rep 6, 178–186 (2017). https://doi.org/10.1007/s13679-017-0261-z

Hallberg, S.J., McKenzie, A.L., Williams, P.T. et al. Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study. Diabetes Ther 9, 583–612 (2018). https://doi.org/10.1007/s13300-018-0373-9

Nicole M Templeman, Søs Skovsø, Melissa M Page, Gareth E Lim, and James D Johnson, A causal role for hyperinsulinemia in obesity, DOI: https://doi.org/10.1530/JOE-16-0449

BRAXTON D. MITCHELL, MICHAEL P. STERN, STEVEN M. HAFFNER, HELEN P. HAZUDA, JUDITH K. PATTERSON, RISK FACTORS FOR CARDIOVASCULAR MORTALITY IN MEXICAN AMERICANS AND NON-HISPANIC WHITES: THE SAN ANTONIO HEART STUDY, American Journal of Epidemiology, Volume 131, Issue 3, March 1990, Pages 423–433, https://doi.org/10.1093/oxfordjournals.aje.a115517

Robert L. Rosenfield, David A. Ehrmann, The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited, Endocrine Reviews, Volume 37, Issue 5, 1 October 2016, Pages 467–520, https://doi.org/10.1210/er.2015-1104

Isabelle N. Colmers, Samantha L. Bowker, Sumit R. Majumdar and Jeffrey A. Johnson, Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: a meta-analysis, DOI: https://doi.org/10.1503/cmaj.112102

Dorothee M. Baur, Jens Klotsche, Ole-Petter, R. Hamnvik, Caroline Sievers, Lars Pieper, Hans-Ulrich Wittchen, Günter K. Stalla, Roland M. Schmid, Stefanos N. Kales, Christos S. Mantzoros, Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort, DOI:https://doi.org/10.1016/j.metabol.2010.09.012

Jia, G., Whaley-Connell, A. & Sowers, J.R. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia 61, 21–28 (2018). https://doi.org/10.1007/s00125-017-4390-4

U.Varma, P.Koutsifeli, V.L.Benson, K.M.Mellor, L.M.D.Delbridge, Molecular mechanisms of cardiac pathology in diabetes – Experimental insights, https://doi.org/10.1016/j.bbadis.2017.10.035

Brian N. Finck; Targeting Metabolism, Insulin Resistance, and Diabetes to Treat Nonalcoholic Steatohepatitis. Diabetes 1 December 2018; 67 (12): 2485–2493.https://doi.org/10.2337/dbi18-0024

Tumminia, A.; Vinciguerra, F.; Parisi, M.; Frittitta, L. Type 2 Diabetes Mellitus and Alzheimer’s Disease: Role of Insulin Signalling and Therapeutic Implications. Int. J. Mol. Sci. 2018, 19, 3306. https://doi.org/10.3390/ijms19113306

Christina C. Lindenmeyer, Arthur J. McCullough, The Natural History of Nonalcoholic Fatty Liver Disease—An Evolving View, Clinics in Liver Disease, https://doi.org/10.1016/j.cld.2017.08.003.

Auriel A. Willette, PhD1,2; Barbara B. Bendlin, PhD3,4; Erika J. Starks, BS3; Alex C. Birdsill, PhD3; Sterling C. Johnson, PhD3,4,5; Bradley T. Christian, PhD6; Ozioma C. Okonkwo, PhD3,4; Asenath La Rue, PhD4; Bruce P. Hermann, PhD4; Rebecca L. Koscik, PhD4; Erin M. Jonaitis, PhD4; Mark A. Sager, MD4; Sanjay Asthana, MD3,5, Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle–Aged Adults at Risk for Alzheimer Disease, JAMA Neurol. 2015;72(9):1013-1020. doi:10.1001/jamaneurol.2015.0613.

MAILBOX-SURPRISE

✔ 10 keto recipes right after signing up
✔ a keto mini course
✔ a new recipe of the week every week for a year
Register quickly for free using the form below!

Subscription Form